PATENT CLAIM ANALYSIS

Application Number: 15901174
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates generally to methods for identifying cancer patients with a poor prognosis, and to therapeutic modalities for improving prognosis by combating metastasis and abrogating chemoresistance in cancer cells. Embodiments of the present invention provide an objective means of prognostication regarding the long-term outcome of an incident of cancer, breast cancer in particular. Therapeutic modalities include immunotherapy and anti-sense therapy. Prognosis is determined by measuring the number of copies of the metadherin gene in the patient's cells.

Claim (Index 12):
The method of  claim 9 , wherein the agent leads to knock-out of the metaherin gene in the chromosome of the individual.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 88.0
- Lexical Diversity: 1.50877
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15004706', '15321337', '12336409', '13963657', '14348365']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7776976012807442
- 35 USC 102 Novelty (BERT): 0.5446364616448666
- Combined Prediction Score: 0.7543914873171564
- Mean Citation Score: 246.366844
- Max Citation Score: 406.5025
- Similarity Product: 267.3936450332403

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test